A survey of aryl hydrocarbon hydroxylase activity in human placental homogenates. 1983

A C Kaelin, and A J Cummings

The mono-oxygenase activity in vitro towards 7-ethoxyresorufin (ERR) and 2,5-diphenyloxazole (PPO) was studied in 108 human placental homogenates obtained from mothers who were either smokers (61), non-smokers (44), or epileptics (3). With both substrates the average placental AHH level among smokers was 50 to 60 times greater than the average level in nonsmokers. Some association was found between levels of placental AHH activity and the number of cigarettes smoked per day by the woman concerned: PPO, r = 0.42, P less than 0.01; ERR, r = 0.39, P less than 0.01. In smokers, placental PPO hydroxylase and ERR O-deethylase activities were highly significantly correlated (r = 0.96, P less than 0.001). In non-smokers the low average levels of AHH activity obtained using both substrates were found to be significantly non-zero: PPO, P less than 0.01; ERR, P less than 0.001. No correlation was found, in either smokers or non-smokers, between placental AHH activity and parameters such as age, body weight, diet (including consumption of tea, coffee and alcohol), number of previous pregnancies or placental and baby birth weights. Women who continued smoking during pregnancy but at a reduced rate still maintained fairly high levels of AHH activity. Administration of carbamazepine appeared to cause some enhancement of placental AHH activity. Phenytoin administration, however, had no apparent effect on the level of enzyme activity.

UI MeSH Term Description Entries
D010088 Oxidoreductases The class of all enzymes catalyzing oxidoreduction reactions. The substrate that is oxidized is regarded as a hydrogen donor. The systematic name is based on donor:acceptor oxidoreductase. The recommended name will be dehydrogenase, wherever this is possible; as an alternative, reductase can be used. Oxidase is only used in cases where O2 is the acceptor. (Enzyme Nomenclature, 1992, p9) Dehydrogenases,Oxidases,Oxidoreductase,Reductases,Dehydrogenase,Oxidase,Reductase
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011248 Pregnancy Complications Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases. Adverse Birth Outcomes,Complications, Pregnancy,Adverse Birth Outcome,Birth Outcome, Adverse,Complication, Pregnancy,Outcome, Adverse Birth,Pregnancy Complication
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006899 Mixed Function Oxygenases Widely distributed enzymes that carry out oxidation-reduction reactions in which one atom of the oxygen molecule is incorporated into the organic substrate; the other oxygen atom is reduced and combined with hydrogen ions to form water. They are also known as monooxygenases or hydroxylases. These reactions require two substrates as reductants for each of the two oxygen atoms. There are different classes of monooxygenases depending on the type of hydrogen-providing cosubstrate (COENZYMES) required in the mixed-function oxidation. Hydroxylase,Hydroxylases,Mixed Function Oxidase,Mixed Function Oxygenase,Monooxygenase,Monooxygenases,Mixed Function Oxidases,Function Oxidase, Mixed,Function Oxygenase, Mixed,Oxidase, Mixed Function,Oxidases, Mixed Function,Oxygenase, Mixed Function,Oxygenases, Mixed Function
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000927 Anticonvulsants Drugs used to prevent SEIZURES or reduce their severity. Anticonvulsant,Anticonvulsant Drug,Anticonvulsive Agent,Anticonvulsive Drug,Antiepileptic,Antiepileptic Agent,Antiepileptic Agents,Antiepileptic Drug,Anticonvulsant Drugs,Anticonvulsive Agents,Anticonvulsive Drugs,Antiepileptic Drugs,Antiepileptics,Agent, Anticonvulsive,Agent, Antiepileptic,Agents, Anticonvulsive,Agents, Antiepileptic,Drug, Anticonvulsant,Drug, Anticonvulsive,Drug, Antiepileptic,Drugs, Anticonvulsant,Drugs, Anticonvulsive,Drugs, Antiepileptic

Related Publications

A C Kaelin, and A J Cummings
January 1992, Toxicology,
A C Kaelin, and A J Cummings
October 1973, Toxicology and applied pharmacology,
A C Kaelin, and A J Cummings
January 1979, Cancer biochemistry biophysics,
A C Kaelin, and A J Cummings
April 1975, Journal of the National Cancer Institute,
A C Kaelin, and A J Cummings
March 1981, The British journal of dermatology,
A C Kaelin, and A J Cummings
March 1984, The British journal of dermatology,
A C Kaelin, and A J Cummings
October 1989, Environmental research,
A C Kaelin, and A J Cummings
July 1981, Cancer research,
A C Kaelin, and A J Cummings
May 1979, British journal of clinical pharmacology,
Copied contents to your clipboard!